Limanaqi, F.; Zecchini, S.; Dino, B.; Strizzi, S.; Cappelletti, G.; Utyro, O.; Vanetti, C.; Garziano, M.; Saulle, I.; Clerici, M.;
et al. Dopamine Reduces SARS-CoV-2 Replication In Vitro through Downregulation of D2 Receptors and Upregulation of Type-I Interferons. Cells 2022, 11, 1691.
https://doi.org/10.3390/cells11101691
AMA Style
Limanaqi F, Zecchini S, Dino B, Strizzi S, Cappelletti G, Utyro O, Vanetti C, Garziano M, Saulle I, Clerici M,
et al. Dopamine Reduces SARS-CoV-2 Replication In Vitro through Downregulation of D2 Receptors and Upregulation of Type-I Interferons. Cells. 2022; 11(10):1691.
https://doi.org/10.3390/cells11101691
Chicago/Turabian Style
Limanaqi, Fiona, Silvia Zecchini, Borana Dino, Sergio Strizzi, Gioia Cappelletti, Olga Utyro, Claudia Vanetti, Micaela Garziano, Irma Saulle, Mario Clerici,
and et al. 2022. "Dopamine Reduces SARS-CoV-2 Replication In Vitro through Downregulation of D2 Receptors and Upregulation of Type-I Interferons" Cells 11, no. 10: 1691.
https://doi.org/10.3390/cells11101691
APA Style
Limanaqi, F., Zecchini, S., Dino, B., Strizzi, S., Cappelletti, G., Utyro, O., Vanetti, C., Garziano, M., Saulle, I., Clerici, M., & Biasin, M.
(2022). Dopamine Reduces SARS-CoV-2 Replication In Vitro through Downregulation of D2 Receptors and Upregulation of Type-I Interferons. Cells, 11(10), 1691.
https://doi.org/10.3390/cells11101691